Skip to content
PeptideSorted

Semaglutide dosage chart: every Wegovy and Ozempic dose, week by week

Written by
Author being confirmed
Last updated
Sources
11 cited
Published

Short answer

Wegovy injection starts at 0.25 mg once a week and rises every 4 weeks through 0.5, 1 and 1.7 mg to 2.4 mg from week 17, with 7.2 mg an option for adults. The Wegovy pill climbs every 30 days from 1.5 mg to 25 mg. Ozempic starts at 0.25 mg weekly and tops out at 2 mg.

What it is
A GLP-1 receptor agonist from Novo Nordisk, sold as Wegovy injection and tablets for weight management and as Ozempic and Rybelsus for type 2 diabetes.
FDA status
FDA approved

Ozempic approved Dec 2017; Wegovy injection Jun 2021; Wegovy tablets Dec 22 2025; Wegovy HD 7.2 mg Mar 19 2026. Compounded semaglutide is not FDA-approved.

Evidence level

FDA label

Dosing comes from the FDA-approved prescribing information.

The Wegovy injection label starts at 0.25 mg once a week, steps up every 4 weeks, and reaches the 2.4 mg maintenance dose at week 17. Semaglutide has more schedules than most drugs because it comes in five forms: Wegovy injection, Wegovy HD, Wegovy tablets, Ozempic injection and the diabetes tablets. The tables below show what each label specifies, and your prescriber chooses the step and the pace.

Wegovy injection dosage chart

Weeks Dose (once weekly) Label role
1 to 4 0.25 mg Starting dose
5 to 8 0.5 mg Escalation
9 to 12 1 mg Escalation
13 to 16 1.7 mg Escalation; also a maintenance option
17 onward 2.4 mg Recommended maintenance dose
After at least 4 weeks on 2.4 mg 7.2 mg (Wegovy HD) Maximum dose; weight reduction in adults only, when more weight loss is clinically indicated
Six rising steps of the Wegovy injection schedule: 0.25, 0.5, 1 and 1.7 mg for 4 weeks each, 2.4 mg from week 17, and 7.2 mg as an option after at least 4 weeks on 2.4 mg.
The Wegovy injection label schedule. 7.2 mg (Wegovy HD) is for adults only. Steps are not drawn to scale.

The maintenance dose depends on the reason for treatment:

  • Weight reduction in adults: 2.4 mg (recommended) or 1.7 mg, with the option of 7.2 mg described above.
  • Weight reduction in adolescents 12 and older: 2.4 mg (recommended) or 1.7 mg. The 7.2 mg dose is not labeled for them.
  • Heart-risk reduction in adults: 2.4 mg (recommended) or 1.7 mg.
  • MASH (fatty liver disease with scarring): 2.4 mg, reduced to 1.7 mg if not tolerated, with re-escalation to be considered.

In STEP 1, the trial behind the 2.4 mg dose, average weight loss was 14.9% at 68 weeks against 2.4% on placebo. The label’s 7.2 mg trial reported 18.8% at 72 weeks against 3.9%.

What happens at each dose step?

The early steps exist mostly to get your stomach used to the drug, and the side effects follow the climb. The Wegovy label says to follow the schedule “to reduce the risk of gastrointestinal adverse reactions.” A pooled analysis of the STEP trials on the semaglutide side effects page found stomach symptoms came most often during or shortly after a dose increase.

Stage What is going on What the label allows
Weeks 1 to 4 (0.25 mg) A starting dose; you are not yet near the dose studied for weight loss 4 weeks, then the next step
Weeks 5 to 16 (0.5 to 1.7 mg) Each step can bring a fresh round of nausea or other stomach symptoms If a dose is not tolerated, consider delaying the next step by 4 weeks
Week 17 on (2.4 mg) The recommended maintenance dose 1.7 mg is also a labeled maintenance dose
After 4+ weeks on 2.4 mg (7.2 mg) An optional step for adults; skin-sensation side effects become more common Only when more weight loss is clinically indicated

Reaching 2.4 mg is not a test you have to pass. The label lists 1.7 mg as a maintenance dose in its own right.

Wegovy pens and their concentrations

Every single-dose Wegovy pen delivers one fixed dose, so nothing is measured.

Pen strength Volume Concentration
0.25 mg 0.5 mL 0.5 mg/mL
0.5 mg 0.5 mL 1 mg/mL
1 mg 0.5 mL 2 mg/mL
1.7 mg 0.75 mL about 2.27 mg/mL
2.4 mg 0.75 mL 3.2 mg/mL
7.2 mg (Wegovy HD) 0.75 mL 9.6 mg/mL

The June 2026 label also lists single-dose prefilled syringes for 0.25 mg to 2.4 mg, and a multi-dose FlexTouch pen holding 9.6 mg in 3 mL (3.2 mg/mL) that gives four 2.4 mg doses. The label says a FlexTouch pen must never be shared, even with a new needle, and that it is not recommended for self-injection by people who are visually impaired.

Wegovy pill dosage chart

Days Dose (once daily) Label role
1 to 30 1.5 mg Starting dose
31 to 60 4 mg Escalation
61 to 90 9 mg Escalation
91 onward 25 mg Maintenance dose

How the label says to take it: one tablet each morning on an empty stomach, with no more than 4 ounces of plain water, swallowed whole. Then wait at least 30 minutes before eating, drinking or taking other oral medicines. Coffee, tea and juice do not count as water here, because the label says no other liquids. A missed tablet is skipped, not doubled.

The label allows switching from the 2.4 mg injection to the 25 mg tablet one week after the last shot, and from the 25 mg tablet to the 2.4 mg injection the day after the last tablet. If 25 mg tablets are not tolerated, it says to consider the 1.7 mg injection.

Ozempic dosage chart

Step Dose (once weekly) Minimum time at this dose
1 0.25 mg 4 weeks (starting dose)
2 0.5 mg 4 weeks
3 1 mg 4 weeks
4 2 mg Ongoing (maximum)

Ozempic’s maintenance dose is 0.5, 1 or 2 mg, chosen by blood sugar response, and a step up is only for people who need more control. For the kidney use the label lists 1 mg. Ozempic multi-dose pens hold 3 mL each: the 2 mg pen (0.68 mg/mL) gives 0.25 mg or 0.5 mg doses, the 4 mg pen (1.34 mg/mL) gives 1 mg, and the 8 mg pen (2.68 mg/mL) gives 2 mg. The label also lists single-dose prefilled syringes of 0.25, 0.5 and 1 mg.

Ozempic tablets and Rybelsus: the diabetes pills

Days Rybelsus (once daily) Ozempic tablets (once daily)
1 to 30 3 mg 1.5 mg
31 to 60 7 mg 4 mg
61 onward 7 mg, or 14 mg if more blood sugar control is needed 4 mg, or 9 mg if more blood sugar control is needed

The two products are different formulations of oral semaglutide. The label says they “are not substitutable on a mg-to-mg basis”: Rybelsus 7 mg matches Ozempic tablets 4 mg, and Rybelsus 14 mg matches Ozempic tablets 9 mg. Both are approved for type 2 diabetes only. The Wegovy pill is a separate product for weight.

When and where do you take it?

Wegovy and Ozempic injections can go in at any time of day, with or without meals, on the same day each week. The label lists the abdomen, thigh or upper arm, and says the time of day and the site can change without changing the dose. Rotate the site with each dose.

A body outline with three shaded injection areas: the abdomen at least 2 inches from the navel, the front of the thigh, and the back of the upper arm.
The three subcutaneous sites named in the Zepbound and Wegovy instructions.

To change your injection day, the Wegovy Medication Guide says your last dose must have been 2 or more days before. The Ozempic label says the same: at least 2 days between doses. The injection sites guide covers technique, and the dose tracker keeps your weeks straight.

What if you miss a dose?

For Wegovy injection, take a missed dose if the next one is more than 2 days away, and skip it if the next one is less than 2 days away. The rules differ by product, so do not assume they transfer:

Product Missed-dose rule on the label
Wegovy injection If the next dose is more than 2 days away, take it as soon as possible. If less than 2 days away, skip it. After 2 or more missed doses in a row, the label says to restart the escalation at a lower dose.
Ozempic injection Take it within 5 days. After 5 days, skip it and resume on the usual day.
Wegovy, Ozempic or Rybelsus tablets Skip it and take the next tablet the following day.

mL and mg to units

100 units = 1 mL

Volume to units

mL
U
100-unit syringe (U-100), marked every 2 units0 units drawn

Type in either box. On every U-100 insulin syringe, 1 mL is 100 units, so 0.1 mL is 10 units and 0.01 mL is 1 unit.

Dose at a known concentration

mg/mL

Draw

25units= 0.25 mL

The concentration is printed on a compounded vial label as mg/mL. If the label gives total mg and total mL instead, divide mg by mL first, or use the reconstitution calculator.

Restarting after a break

If you missed 2 or more weekly Wegovy doses in a row, do not simply pick up where you left off. The label says to restart the escalation at a lower dose to reduce the risk of stomach side effects, and the Medication Guide says to contact your healthcare provider about how to restart. Which step you restart from is the prescriber’s call.

How many units is a dose of compounded semaglutide?

Divide the dose in mg by the vial’s concentration in mg/mL, then multiply by 100. Compounded semaglutide comes in multi-dose vials at a concentration the pharmacy sets, so the dose has to be converted into units on a U-100 insulin syringe.

A U-100 insulin syringe marked from 0 to 100 units, filled to 10 units, with 10 units equal to 0.1 mL, 50 units to 0.5 mL and 100 units to 1 mL.
On a U-100 insulin syringe, 100 units is always 1 mL. Units measure liquid, not how much drug is in it.

The table uses two worked examples. A 5 mg/mL semaglutide product appears in a September 2026 FDA warning letter, and the FDA’s 2024 dosing-error alert describes 0.25 mg as 5 units, which is the same concentration.

Label dose Units at 2.5 mg/mL Units at 5 mg/mL
0.25 mg 10 units 5 units
0.5 mg 20 units 10 units
1 mg 40 units 20 units
1.7 mg 68 units 34 units
2 mg (Ozempic maximum) 80 units 40 units
2.4 mg 96 units 48 units

The calculator above handles any other concentration, and the mg/mL to units converter works for other drugs. If your pharmacy sent a vial at another strength, these two columns do not apply to you. The compounded semaglutide guide explains what to check on the label.

Common semaglutide dosing mistakes

Most of these come straight from the labels or from FDA error reports.

  • Reading units as milligrams. The FDA has reported patients who drew 50 units instead of 5, and prescribers who wrote 25 units when they meant 5.
  • Doubling up after a missed dose. The label’s overdose effects are severe nausea, severe vomiting and severe low blood sugar. Poison Help is 1-800-222-1222.
  • Resuming the old dose after a long gap. After 2 or more missed Wegovy doses, the label says to go back to a lower dose.
  • Treating Rybelsus and Ozempic tablets as interchangeable. They are not, milligram for milligram.
  • Taking the pill with coffee, or breaking it. The label says water only, and to swallow it whole, with no splitting, crushing or chewing.
  • Taking more than one tablet a day. The label sets one a day.
  • Combining products. The Wegovy label says it is not recommended with another semaglutide product or another GLP-1 drug.
  • Sharing a multi-dose pen. Never, even with a new needle.
  • Keeping a pen too long. A single-dose Wegovy pen can stay out of the fridge, at 46 to 86°F, for up to 28 days. An in-use FlexTouch or Ozempic pen is good for 56 days.

Who should not follow these schedules at all

Every semaglutide label carries a boxed warning about thyroid C-cell tumors seen in rodents. The labels say semaglutide must not be used by anyone with a personal or family history of medullary thyroid carcinoma or with Multiple Endocrine Neoplasia syndrome type 2, or after a serious allergic reaction to it. The label says its use in type 1 diabetes has not been evaluated, and it should not be combined with another GLP-1 drug. The label also advises stopping Wegovy at least 2 months before a planned pregnancy. The doses here describe what the labels say. Your prescriber decides what applies to you.

Compare

Getting semaglutide legitimately

Affiliate disclosure: some links below pay us a referral fee. It never changes the price you pay or the order we list providers.

Through your own doctor

Any licensed prescriber can write a prescription for an FDA-approved GLP-1 if you meet the label criteria. Insurance coverage for weight management varies; ask the office to run a benefits check first.

Through a telehealth provider

Look for a real consultation with a licensed clinician, a named pharmacy, and a clear statement of whether you are getting the brand product or a compounded version. Avoid any site that ships without a consult.

Provider comparison coming once we have verified pricing and pharmacy sourcing for each program. Until then, the two routes above are the only ones we recommend.

Recent news on this

Peptide news, sorted. Plus the printable dose chart.

Sorted, every Tuesday: the week's peptide and GLP-1 news in five minutes: FDA moves, new studies explained, and price changes. Subscribe and the one-page dose and injection-site chart arrives first.

Double opt-in. One click to unsubscribe. No dosing advice by email.

Questions people ask

How long do you stay on 0.25 mg of semaglutide?
Four weeks on both Wegovy and Ozempic. The labels treat 0.25 mg as a starting dose to help the stomach adjust, and then move up to 0.5 mg.
What is the highest dose of semaglutide?
For weight management, 7.2 mg once weekly as Wegovy HD, for adults who have tolerated 2.4 mg for at least 4 weeks and need more weight loss. For type 2 diabetes, Ozempic tops out at 2 mg a week. The Wegovy pill tops out at 25 mg a day.
What if I miss a Wegovy dose?
The label says: if the next dose is more than 2 days away, take the missed dose as soon as possible; if it is less than 2 days away, skip it. After 2 or more missed doses in a row, the label says to restart the escalation at a lower dose, so call your prescriber. A missed Wegovy pill is skipped and the next one taken the following day.
Can I go up to the next dose sooner than 4 weeks?
The labels do not describe going faster. The Wegovy schedule moves up every 4 weeks to lower the risk of stomach side effects, and if a dose is not tolerated the label allows delaying the next step by 4 weeks.
How many units is 0.25 mg of compounded semaglutide?
It depends on the vial's concentration. At 5 mg/mL, 0.25 mg is 5 units on a U-100 insulin syringe. At 2.5 mg/mL it is 10 units. The FDA has reported patients drawing 50 units instead of 5, a tenfold overdose, so read the mg/mL on the label first.

Sources

Primary sources first: FDA labels and documents, peer-reviewed trials, registries.

  1. 1Wegovy (semaglutide) injection and tablets prescribing information and Medication Guide, Novo Nordisk, revised 6/2026novo-pi.com
  2. 2Wegovy (semaglutide) injection and tablets prescribing information, Novo Nordisk, revised 6/2026, via DailyMeddailymed.nlm.nih.gov
  3. 3Wegovy prescribing information, revised 3/2026, via FDA (NDA 215256)accessdata.fda.gov
  4. 4Ozempic (semaglutide) injection prescribing information, Novo Nordisk, revised 5/2026, via DailyMeddailymed.nlm.nih.gov
  5. 5Ozempic (semaglutide) injection prescribing information, revised 5/2026, via FDA (NDA 209637, supplement 38)accessdata.fda.gov
  6. 6Ozempic tablets and Rybelsus (oral semaglutide) prescribing information, Novo Nordisk, revised 1/2026, via DailyMeddailymed.nlm.nih.gov
  7. 7FDA press release: FDA approves fourth product under National Priority Voucher program, higher dose semaglutide, Mar 19 2026fda.gov
  8. 8FDA. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products, Jul 26 2024fda.gov
  9. 9FDA warning letter 738238 to a Texas 503A compounding pharmacy, Sep 18 2026 (lists a semaglutide product at 5 mg/mL)fda.gov
  10. 10Wharton S et al. Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity. Diabetes Obes Metab 2022;24:94-105pubmed.ncbi.nlm.nih.gov
  11. 11Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med 2021pubmed.ncbi.nlm.nih.gov

PeptideSorted Editorial Team

Editorial review

The PeptideSorted editors check every guide against its cited sources before publication: each number against its FDA label, trial or registry, the FDA status against current FDA and HHS documents, and the wording against our describe-never-prescribe rule. Licensed clinicians who join the review panel are listed by name on the editorial team page.

This page was checked against its cited sources by the PeptideSorted editorial team. Licensed clinicians on our review panel are listed on the editorial team page. Every health page cites primary sources and shows its review date. Read the editorial policy and how medical review works, or report an error via corrections. Educational only; not medical advice.